FibroBiologics: Of That Certain Current Report On Form 8k Originally Filed By The Company With The U.s. Securities And Exchange Commission On December 23, 2024 (the “original Form 8k”). This Amendment Is Being Filed To Provide The Total Number Of Shares Of The Company’s Common Stock That May Be Issued Upon Conversion Of The Promissory Notes. This Amendment Does Not Amend Any Other Item Of The Original Form 8k And All Other Information Previously Reported In Or Filed With The Original Form 8k (including The Other Information In Item 3.02) Is Hereby Incorporated By Reference Into This Amendment

Show full article

This functionality is available for registred users only

• Full name
  FibroBiologics Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***